Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: A review

被引：23

作者：

Porte, Melanie ^{[1
,3
]}

Chaleat-Valayer, Emmanuelle ^{[2
]}

Patte, Karine ^{[3
]}

D'Anjou, Marie-Charlotte ^{[4
]}

Boulay, Christophe ^{[5
]}

Laffont, Isabelle ^{[6
]}

机构：

[1] CHU Nimes, PM&R Dept, Nimes, France

[2] CMCR Massues Lyon, PM&R Dept, Lyon, France

[3] Inst St Pierre Palavas les Flots, PM&R Dept, Palavas Les Flots, France

[4] CHU St Etienne, Coordinat Unit Pediat PM&R, St Etienne, France

[5] CH La Timone Marseille, Pediat Orthoped Surg Unit, Marseille, France

[6] CHU Montpellier, PM&R Dept, Montpellier, France

来源：

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY | 2014年 / 18卷 / 06期

关键词：

Sialorrhea; Cerebral palsy; Children; Botulinum toxin; Efficacy; Procedure; RANDOMIZED-TRIAL; SALIVARY-GLANDS; DOUBLE-BLIND; MANAGEMENT; SECONDARY; EFFICACY;

D O I：

10.1016/j.ejpn.2014.05.007

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Background: After the age of 4 years, drooling becomes pathological and impacts the quality of life of children with cerebral palsy. Intraglandular injection of Botulinum toxin is one of the treatments available to limit this phenomenon. Aims: The objectives of this review were to validate the efficacy of Botulinum toxin injections for drooling in children with cerebral palsy, determine recommendations and identify potential side effects. Methods: We conducted a literature review from 2001 in the following databases: Embase, Pubmed and Cochrane using the keywords: sialorrhea, drooling, hypersalivation, Botulinum toxin, cerebral palsy and children. Only the articles evaluating the efficacy of Botulinum toxin in children with cerebral palsy over the age of 4 were researched. Results: Eight studies were found: 2 case studies, 3 open and non-controlled studies and 3 randomized controlled trials. Efficacy results in this indication are quite encouraging and the use of BTX injections is safe but the overall level of evidence of these studies was quite low. Conclusion: However, intraglandular injection of Botulinum toxin has a place among the therapeutic array available for the management of sialorrhea in this population even if no standardized protocol is available yet. (C) 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

引用

页码：649 / 657

页数：9

共 45 条

[1] Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy [J].

Banerjee, K. J. ;

Glasson, C. ;

O'Flaherty, S. J. .

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (11) :883-887

[2] Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses [J].

Basciani, Mario ;

di Rienzo, Filomena ;

Fontana, Andrea ;

Copetti, Massimiliano ;

Pellegrini, Fabio ;

Intiso, Domenico .

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2011, 53 (06) :559-564

[3] Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands [J].

Berweck, Steffen ;

Schroeder, A. Sebastian ;

Lee, Seung-Hee ;

Bigalke, Hans ;

Heinen, Florian .

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2007, 49 (01) :62-64

[4]

Bhayani M K., 2008, Operative Techniques in Otolaryngology-Head and Neck Surgery, V19, DOI [10.1016/j.otot.2008.10.008, DOI 10.1016/J.OTOT.2008.10.008]

[5] Botulinum toxin A as a treatment for excessive drooling in children [J].

Bothwell, JE ;

Clarke, K ;

Dooley, JM ;

Gordon, KE ;

Anderson, R ;

Wood, EP ;

Camfield, CS ;

Camfield, PR .

PEDIATRIC NEUROLOGY, 2002, 27 (01) :18-22

[6] A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE [J].

Chaleat-Valayer, Emmanuelle ;

Parratte, Bernard ;

Colin, Cyrille ;

Denis, Angelique ;

Oudin, Severine ;

Berard, C. ;

Bernard, J. C. ;

Bourg, V. ;

Deleplanque, B. ;

Dulieu, I. ;

Evrard, P. ;

Filipetti, P. ;

Flurin, V. ;

Gallien, P. ;

Heron-Long, B. ;

Hodgkinson, I. ;

Husson, I. ;

Jaisson-Hot, I. ;

Maupas, E. ;

Meurin, F. ;

Monnier, G. ;

Perennou, D. ;

Pialoux, B. ;

Quentin, V. ;

Moreau, M. Simonetta ;

Schneider, M. ;

Yelnik, Alain ;

Marque, Philippe .

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2011, 15 (05) :439-448

[7] Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease [J].

Dogu, O ;

Apaydin, D ;

Sevim, S ;

Talas, DU ;

Aral, M .

CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 106 (02) :93-96

[8] Clinical practice Swallowing problems in cerebral palsy [J].

Erasmus, Corrie E. ;

van Hulst, Karen ;

Rotteveel, Jan J. ;

Willemsen, Michel A. A. P. ;

Jongerius, Peter H. .

EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (03) :409-414

[9] Does Motor Performance Matter in Botulinum Toxin Efficacy for Drooling? [J].

Erasmus, Corrie E. ;

Scheffer, Arthur R. T. ;

van Hulst, Karen ;

van Limbeek, Jacques ;

van den Hoogen, Frank J. A. ;

Rotteveel, Jan J. ;

Jongerius, Peter H. .

PEDIATRIC NEUROLOGY, 2011, 45 (02) :95-99

[10] Thickened saliva after effective management of drooling with botulinum toxin A [J].

Erasmus, Corrie E. ;

Van Hulst, Karen ;

Van den Hoogen, Frank Ja ;

Van Limbeek, Jacques ;

Roeleveld, Nel ;

Veerman, Enno Ci ;

Rotteveel, Jan J. ;

Jongerius, Peter H. .

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2010, 52 (06) :E114-E118

← 1 2 3 4 5 →